Proteome-Wide Profiling of Cellular Targets Modified by Dopamine
Par un écrivain mystérieux
Description
Frontiers Mapping the O-GlcNAc Modified Proteome: Applications for Health and Disease
Developing Photoaffinity Probes for Dopamine Receptor D2 to Determine Targets of Parkinson's Disease Drugs
Dopamine modification of glycolytic enzymes impairs glycolysis: possible implications for Parkinson's disease, Cell Communication and Signaling
Subcellular proteomics of dopamine neurons in the mouse brain
Proteome-Wide Profiling of Cellular Targets Modified by Dopamine Metabolites Using a Bio-Orthogonally Functionalized Catecholamine
Global ubiquitinome profiling identifies NEDD4 as a regulator of Profilin 1 and actin remodelling in neural crest cells
Proteomic analysis of the human hippocampus identifies neuronal pentraxin 1 (NPTX1) as synapto‐axonal target in late‐stage Parkinson's disease - Warth Perez Arias - 2023 - Journal of Neurochemistry - Wiley Online Library
Subcellular proteomics of dopamine neurons in the mouse brain
Quantitative Chemoproteomic Profiling with Data-Independent Acquisition-Based Mass Spectrometry
Proteome-Wide Profiling of Cellular Targets Modified by Dopamine Metabolites Using a Bio-Orthogonally Functionalized Catecholamine
depuis
par adulte (le prix varie selon la taille du groupe)
